Last update 01 Nov 2024
Empi, Inc.

Empi, Inc.

Subsidiary Company|
1977|
Minnesota, United States
|
5,000-10,000
| NASDAQ: EMPI|
www.empi.com

Overview

Related

1
Drugs associated with Empi, Inc.
Epinephrine/Lidocaine Hydrochloride
Target
SCNA x adrenergic receptor
Mechanism
SCNA blockers [+1]
Active Org.
Fresenius Kabi USA LLCFresenius Kabi USA LLC [+1]
Originator Org.
Fresenius Kabi AGFresenius Kabi AG
Active Indication
Anesthesia
Inactive Indication
Dermatophilosis [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date19 Nov 1948
1
Clinical Trials associated with Empi, Inc.
ISRCTN15816734 / CompletedNot Applicable
The effect of home electrical stimulation and intra-operative femoral nerve blockage on outcomes after anterior cruciate ligament reconstruction: a prospective, randomized controlled trial with cross-over design
100 Clinical Results associated with Empi, Inc.
Login to view more data
0 Patents (Medical) associated with Empi, Inc.
Login to view more data
100 Deals associated with Empi, Inc.
Login to view more data
100 Translational Medicine associated with Empi, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Epinephrine/Lidocaine Hydrochloride
 ( SCNA x adrenergic receptor )		Pain
More
Withdrawn
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free